The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer

[1]  D. Yee,et al.  Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. , 1992, Journal of the National Cancer Institute.

[2]  P. Campbell,et al.  Insulin‐Like growth factor binding protein (IGFBP) inhibits igf action on human osteosarcoma cells , 1991, Journal of cellular physiology.

[3]  N. Rosen,et al.  Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. , 1991, Cancer research.

[4]  R. Daly,et al.  Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[5]  D. Clemmons,et al.  Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Conover,et al.  Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. , 1991, Endocrinology.

[7]  D. Clemmons,et al.  Secretion and biological actions of insulin‐like growth factor binding proteins in two human tumor‐derived cell lines in vitro , 1991, Journal of cellular physiology.

[8]  M. Dehoff,et al.  Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. , 1991, Endocrinology.

[9]  N. Ling,et al.  Isolation and molecular cloning of insulin-like growth factor-binding protein-6. , 1991, Molecular endocrinology.

[10]  N. Ling,et al.  Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. , 1991, The Journal of biological chemistry.

[11]  J. Hammond,et al.  Identification and regulation of insulin-like growth factor binding proteins produced by hormone-dependent and -independent human breast cancer cell lines , 1991, Molecular and Cellular Endocrinology.

[12]  J. Culouscou,et al.  Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein. , 1991, Cancer research.

[13]  D. Yee,et al.  Identification of insulin-like growth factor binding proteins in breast cancer cells , 1991, Breast Cancer Research and Treatment.

[14]  D. Leroith,et al.  Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation. , 1991, Endocrinology.

[15]  C. Blat,et al.  IGFBP-1, an insulin like growth factor binding protein, is a cell growth inhibitor. , 1991, Biochemical and biophysical research communications.

[16]  R. Baxter,et al.  Insulin‐Like Growth Factor (IGF) Binding Proteins: the Role of Serum IGFBPs in Regulating IGF Availability , 1991, Acta paediatrica Scandinavica. Supplement.

[17]  B. van der Burg,et al.  Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells. , 1990, Cancer research.

[18]  M. Johnson,et al.  Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. , 1990, The Journal of biological chemistry.

[19]  S. Mohan,et al.  Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation. , 1990, Molecular endocrinology.

[20]  C. Osborne,et al.  Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. , 1990, Endocrinology.

[21]  O. Itkonen,et al.  Insulin-like growth factor-binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis. , 1990, Biochemical and biophysical research communications.

[22]  D. Clemmons,et al.  A factor contained in plasma is required for IGF binding protein‐1 to potentiate the effect of IGF‐I on smooth muscle cell DNA synthesis , 1990, Journal of cellular physiology.

[23]  N. Ling,et al.  Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human. , 1990, Molecular endocrinology.

[24]  G. Gray,et al.  Characterization and hormonal regulation of radioimmunoassayable IGF-I (insulin-like growth factor I) like activity and IGF-binding proteins secreted by human breast cancer cells. , 1990, Anticancer research.

[25]  L. Demers,et al.  Polyamine involvement in basal and estradiol-stimulated insulin-like growth factor I secretion and action in breast cancer cells in culture , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  B. Katzenellenbogen,et al.  Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen. , 1990, Endocrinology.

[27]  C. Osborne,et al.  Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. , 1989, Molecular endocrinology.

[28]  Christopher C. Binkert,et al.  Cloning, sequence analysis and expression of a cDNA encoding a novel insulin‐like growth factor binding protein (IGFBP‐2). , 1989, The EMBO journal.

[29]  M. Ranke,et al.  Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. , 1989, Endocrinology.

[30]  D. Wilson,et al.  Characterization of insulin-like growth factor binding proteins from human breast cancer cells. , 1989, Molecular endocrinology.

[31]  D. Yee,et al.  Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. , 1989, Molecular endocrinology.

[32]  D. Yee,et al.  The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. , 1989, Biochemical and biophysical research communications.

[33]  D. Yee,et al.  Insulin-like growth factor II mRNA expression in human breast cancer. , 1988, Cancer research.

[34]  W. Wood,et al.  Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. , 1988, Molecular endocrinology.

[35]  R. Baxter,et al.  Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. , 1988, Biochemical and biophysical research communications.

[36]  M. T. Brewer,et al.  Cloning, characterization, and expression of a human insulin-like growth factor binding protein. , 1988, Biochemical and biophysical research communications.

[37]  R. Voutilainen,et al.  Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. , 1988, Endocrinology.

[38]  D. Powell,et al.  Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. , 1988, Molecular endocrinology.

[39]  D. Wilson,et al.  Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. , 1988, Biochemical and biophysical research communications.

[40]  A. Nicolin,et al.  Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro , 1987, Molecular and Cellular Endocrinology.

[41]  D. Clemmons,et al.  An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Dickson,et al.  Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. , 1987, Endocrine reviews.

[43]  M. Sporn,et al.  Mechanism of action of retinoids. , 1986, Journal of the American Academy of Dermatology.

[44]  D. Kaufman,et al.  Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. , 1986, Cancer research.

[45]  C. Marth,et al.  Effect of 4-hydroxyphenylretinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. , 1985, Journal of the National Cancer Institute.

[46]  J. T. Forbes,et al.  Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice. , 1984, Cancer research.

[47]  A. Herington,et al.  Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction. , 1981, Endocrinology.

[48]  G. Smith,et al.  Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[49]  F Vignon,et al.  [Growth factors and cancer]. , 1994, Journal de gynecologie, obstetrique et biologie de la reproduction.

[50]  K J Cullen,et al.  Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. , 1992, Molecular endocrinology.

[51]  R. Baxter,et al.  Binding proteins for the insulin-like growth factors: structure, regulation and function. , 1989, Progress in growth factor research.